NCT02455557 2026-02-25SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaRoswell Park Cancer InstitutePhase 2 Active not recruiting66 enrolled 11 charts
NCT01903330 2025-03-05ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma MultiformeEpitopoietic Research CorporationPhase 2 Active not recruiting84 enrolled